Structural Heart Devices Market Expansion Driven by Innovation and Regional Demand

The structural heart devices market is witnessing significant growth as the prevalence of valvular, congenital, and other structural cardiac conditions increases worldwide. According to DelveInsight, the market was valued at USD 12.94 billion in 2025 and is anticipated to reach USD 30.62 billion by 2034, expanding at a CAGR of 10.08% from 2026 to 2034. Rising adoption of catheter-based procedures, technological innovation, expanding treatment indications, and demand for shorter recovery periods are supporting this expansion.

Structural Heart Devices Market: Increasing Burden of Cardiac Disorders

The rising incidence of structural and valvular heart diseases is creating sustained demand for advanced cardiac interventions. Aortic valve stenosis affects approximately 9 million people worldwide, while mitral regurgitation impacts nearly 24 million. Congenital conditions, including atrial septal defects, ventricular septal defects, and patent foramen ovale, further contribute to the need for corrective procedures. Without appropriate treatment, these abnormalities may result in complications such as heart failure, arrhythmias, and pulmonary hypertension, strengthening the requirement for effective repair and replacement technologies.

Structural Heart Devices Market: Advancements in Treatment Technologies

Technological progress is reshaping the management of structural cardiac disorders. New-generation transcatheter heart valves, mitral and tricuspid repair systems, annuloplasty devices, occluders, and left atrial appendage closure technologies are being designed to improve procedural accuracy and patient outcomes. Improvements in three-dimensional echocardiography, real-time imaging, and artificial intelligence-supported procedural navigation are further helping clinicians manage complex interventions. As device performance and procedural precision improve, minimally invasive treatment options are becoming accessible to a broader patient population.

Structural Heart Devices Market: Shift Toward Minimally Invasive Procedures

The increasing preference for catheter-based interventions over conventional open-heart surgery represents another major growth factor. Transcatheter procedures can potentially reduce surgical trauma, hospitalization duration, infection risk, and recovery time. These advantages are particularly relevant for elderly patients and individuals with multiple comorbidities who may not be suitable candidates for conventional surgery.

Transcatheter aortic valve replacement has consequently become an established option for numerous patients with severe aortic stenosis. Its use has progressively expanded beyond high-risk patients toward intermediate- and selected lower-risk populations, creating additional opportunities for device manufacturers.

Structural Heart Devices Market: Replacement Devices Maintain Product Leadership

Replacement devices accounted for approximately 63% of the market in 2025, making them the leading product category. This segment encompasses mechanical and tissue-based heart valves used in surgical as well as transcatheter procedures. Growing utilization of transcatheter aortic valve replacement for severe aortic stenosis has significantly contributed to demand.

Tissue valves continue to attract interest because of their favorable hemodynamic performance and reduced requirement for long-term anticoagulation compared with mechanical alternatives. Mechanical valves, meanwhile, remain important because of their durability and suitability for patients requiring long-term valve replacement.

Repair technologies are also gaining traction as transcatheter mitral and tricuspid procedures advance. Improvements in annuloplasty systems, occluders, and other repair technologies are expected to expand the range of patients who can benefit from less invasive structural heart interventions.